Terns Pharmaceuticals, Inc.TERNNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-100.97M
↓ 62% below average
Average (6y)
$-62.38M
Historical baseline
Range
High:$-18.39M
Low:$-101.68M
CAGR
+32.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-100.97M | +0.7% |
| 2023 | $-101.68M | -66.7% |
| 2022 | $-61.00M | -23.6% |
| 2021 | $-49.35M | -34.7% |
| 2020 | $-36.63M | +46.6% |
| 2019 | $-68.64M | -273.3% |
| 2018 | $-18.39M | - |